These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10077475)
21. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Okarvi SM; Al Jammaz I Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867 [TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours. Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924 [TBL] [Abstract][Full Text] [Related]
24. Glycation methods for bombesin analogs containing the (NalphaHis)Ac chelator for 99mTc(CO)3 radiolabeling. Brans L; Maes V; García-Garayoa E; Schweinsberg C; Daepp S; Bläuenstein P; Schubiger PA; Schibli R; Tourwé DA Chem Biol Drug Des; 2008 Dec; 72(6):496-506. PubMed ID: 19016795 [TBL] [Abstract][Full Text] [Related]
25. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685 [TBL] [Abstract][Full Text] [Related]
26. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models. Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957 [TBL] [Abstract][Full Text] [Related]
27. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors. Shirmardi SP; Gandomkar M; Maragheh MG; Shamsaei M Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector. Abd-Elgaliel WR; Gallazzi F; Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Lever SZ Bioconjug Chem; 2008 Oct; 19(10):2040-8. PubMed ID: 18808168 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of bombesin analogues conjugated to two different triazolyl-derived chelators for (99m)Tc labeling. Brans L; García-Garayoa E; Schweinsberg C; Maes V; Struthers H; Schibli R; Tourwé D ChemMedChem; 2010 Oct; 5(10):1717-25. PubMed ID: 20806312 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent. Okarvi SM; al-Jammaz I Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569 [TBL] [Abstract][Full Text] [Related]
32. Kit formulation for 99mTc-labeling of HYNIC-βAla-Bombesin((7-14)). de Barros AL; Mota Ld; Ferreira Cde A; Cardoso VN Appl Radiat Isot; 2012 Oct; 70(10):2440-5. PubMed ID: 22871450 [TBL] [Abstract][Full Text] [Related]
33. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. La Bella R; Garcia-Garayoa E; Langer M; Bläuenstein P; Beck-Sickinger AG; Schubiger PA Nucl Med Biol; 2002 Jul; 29(5):553-60. PubMed ID: 12088725 [TBL] [Abstract][Full Text] [Related]
35. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]